We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
신규 편입 · 포트폴리오 비중 0.00%
신규 편입 · 포트폴리오 비중 0.00%
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
OPKO Health Inc (OPK) Institutional Confidence - TradingKey
OPKO Health Inc (OPK) Institutional Confidence TradingKey
Zacks Research Has Weak Estimate for OPKO Health Q2 Earnings - MarketBeat
Zacks Research Has Weak Estimate for OPKO Health Q2 Earnings MarketBeat
OPKO Health Q1 2026 Earnings: Narrowly Beats Estimates as Net Loss Per Share Stabilizes - Negative Surprise Momentum - DonanımHaber
OPKO Health Q1 2026 Earnings: Narrowly Beats Estimates as Net Loss Per Share Stabilizes - Negative Surprise Momentum DonanımHaber
OPKO Health (OPK) up 17.1% since last earnings report: Can it continue? - MSN
OPKO Health (OPK) up 17.1% since last earnings report: Can it continue? MSN
OPK - Opko Health Inc Options - Finviz
OPK - Opko Health Inc Options Finviz
OPKO Health Inc focuses on diagnostics and pharmaceuticals as investors weigh long-term prospects - AD HOC NEWS
OPKO Health Inc focuses on diagnostics and pharmaceuticals as investors weigh long-term prospects AD HOC NEWS
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.1 | — | — | $149.95M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.1 | — | — | $529.5M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.13 | — | — | $355.87M | Reported |
| FY2025 Q1 | 2024. 03. 31. | Time TBD | — | — | — | — | $173.69M | Reported |
No research actions to show.
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 734,747 | $925.78K | 0.00% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 170,000 | $193.8K | 0.00% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 93,335 | $106.4K | 0.00% | — | New position |